Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.PloS one · 2015
   Article
2. Is hepatic glucose production increased in type 2 diabetes mellitus?Current diabetes reports · 2002
   Review
3. Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy.The Journal of clinical investigation · 2000
   Article
4. Insulin action in skeletal muscle from patients with NIDDM.Molecular and cellular biochemistry · 1998
   Review
5. Pathophysiology of non-insulin-dependent diabetes and the search for candidate genes: dangerous liaisons?Acta diabetologica · 1996
   Review
6. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.Drugs · 1995 · on this map
   Review
7. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.Diabetologia · 1995
   Article
8. Metabolism of energy-yielding substrates in patients with liver cirrhosis.The Clinical investigator · 1994
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as